1. Home
  2. PRQR vs RDCM Comparison

PRQR vs RDCM Comparison

Compare PRQR & RDCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRQR
  • RDCM
  • Stock Information
  • Founded
  • PRQR 2012
  • RDCM 1985
  • Country
  • PRQR Netherlands
  • RDCM Israel
  • Employees
  • PRQR N/A
  • RDCM N/A
  • Industry
  • PRQR Biotechnology: Pharmaceutical Preparations
  • RDCM Computer peripheral equipment
  • Sector
  • PRQR Health Care
  • RDCM Technology
  • Exchange
  • PRQR Nasdaq
  • RDCM Nasdaq
  • Market Cap
  • PRQR 179.1M
  • RDCM 210.6M
  • IPO Year
  • PRQR 2014
  • RDCM 1997
  • Fundamental
  • Price
  • PRQR $2.13
  • RDCM $13.58
  • Analyst Decision
  • PRQR Strong Buy
  • RDCM Strong Buy
  • Analyst Count
  • PRQR 8
  • RDCM 2
  • Target Price
  • PRQR $8.88
  • RDCM $16.00
  • AVG Volume (30 Days)
  • PRQR 362.3K
  • RDCM 69.9K
  • Earning Date
  • PRQR 08-07-2025
  • RDCM 08-06-2025
  • Dividend Yield
  • PRQR N/A
  • RDCM N/A
  • EPS Growth
  • PRQR N/A
  • RDCM 111.69
  • EPS
  • PRQR N/A
  • RDCM 0.53
  • Revenue
  • PRQR $21,212,711.00
  • RDCM $63,477,000.00
  • Revenue This Year
  • PRQR N/A
  • RDCM $18.09
  • Revenue Next Year
  • PRQR N/A
  • RDCM $11.46
  • P/E Ratio
  • PRQR N/A
  • RDCM $25.97
  • Revenue Growth
  • PRQR 85.91
  • RDCM 18.21
  • 52 Week Low
  • PRQR $1.07
  • RDCM $9.08
  • 52 Week High
  • PRQR $4.62
  • RDCM $15.98
  • Technical
  • Relative Strength Index (RSI)
  • PRQR 64.73
  • RDCM 58.69
  • Support Level
  • PRQR $1.89
  • RDCM $12.90
  • Resistance Level
  • PRQR $2.54
  • RDCM $13.99
  • Average True Range (ATR)
  • PRQR 0.14
  • RDCM 0.70
  • MACD
  • PRQR 0.01
  • RDCM 0.10
  • Stochastic Oscillator
  • PRQR 43.06
  • RDCM 81.53

About PRQR ProQR Therapeutics N.V.

ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.

About RDCM Radcom Ltd.

Radcom Ltd Ltd is engaged in providing network intelligence, 5G ready cloud-native, network intelligence solutions for telecom operators transitioning to 5G. The company has a network intelligence solution for 5G namely Radcom ACE. Its products consist of Radcom Network Visibility, Radcom Service Assurance, and Radcom Network Insights. It has offices in Israel, the United States, Brazil, and India. Key revenue is derived from sales in North America.

Share on Social Networks: